In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study
A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…
Read More
A Novel Drug Screening Platform Revolutionizes Approach to Neurological and Psychiatric Disorders by Targeting Protein Expression Imbalances
Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Innovative Bioengineered Bone Marrow-on-a-Chip Platform Replicates Human Hematopoietic Systems to Revolutionize Drug Development and Space Exploration
In a landmark advancement for regenerative medicine and bioengineering, a multidisciplinary team of researchers from the University of Pennsylvania School…
Read More
Billion Cell Atlas Unveiled: A New Horizon for AI-Driven Drug Discovery and Disease Understanding
In a landmark initiative poised to revolutionize pharmaceutical research, scientists have announced the launch of the Billion Cell Atlas, an…
Read More
Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More
QIAGEN Digital Insights Partners with NVIDIA to Revolutionize AI-Driven Drug Discovery
The integration of NVIDIA’s accelerated computing and BioNeMo platform with QIAGEN Digital Insights’ bioinformatics capabilities is poised to usher in…
Read More
